Basic Information | Post buying leads | Suppliers |
Name |
Tipepidine hibenzate |
EINECS | 250-481-8 |
CAS No. | 31139-87-4 | Density | 1.193g/cm3 |
PSA | 134.32000 | LogP | 6.59640 |
Solubility | N/A | Melting Point |
187-190° |
Formula | C15H17NS2.C14H10O4 | Boiling Point | 403 °C at 760 mmHg |
Molecular Weight | 517.67 | Flash Point | 197.5 °C |
Transport Information | N/A | Appearance | COA |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Benzoic acid,2-(4-hydroxybenzoyl)-,compd. with 3-(di-2-thienylmethylene)-1-methylpiperidine (1:1);Benzoic acid, o-(p-hydroxybenzoyl)-, compd. with 3-(di-2-thienylmethylene)-1-methylpiperidine (1:1);Asverin H;3-(dithiophen-2-ylmethylidene)-1-methyl-2,4,5,6-tetrahydropyridine; 2-(4-hydroxybenzoyl)benzoate;o-(p-Hydroxybenzoyl)benzoic acid, compound with 3-(di-2-thienylmethylene)-1-methylpiperidine (1:1); |
The IUPAC name of Tipepidine hibenzate is 3-(dithiophen-2-ylmethylidene)-1-methylpiperidine; 2-(4-hydroxybenzoyl)benzoic acid. With the CAS registry number 31139-87-4, it is also named as Asverin H. The product's classification code is Drug / Therapeutic Agent. Besides, it should be stored in sealed containers in a cool and dry place. In addition, its molecular formula is C15H17NS2.C14H10O4 and molecular weight is 517.66.
The other characteristics of Tipepidine hibenzate can be summarized as: (1)ACD/LogP: 5.01; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): 2.43; (4)ACD/LogD (pH 7.4): 4.12; (5)ACD/BCF (pH 5.5): 9.94; (6)ACD/BCF (pH 7.4): 485.57; (7)ACD/KOC (pH 5.5): 33.36; (8)ACD/KOC (pH 7.4): 1629.1; (9)#H bond acceptors: 1; (10)#Freely Rotating Bonds: 2; (11)Polar Surface Area: 56.48Å2; (12)Flash Point: 197.5 °C; (13)Enthalpy of Vaporization: 65.42 kJ/mol; (14)Boiling Point: 403 °C at 760 mmHg; (15)Vapour Pressure: 1.05E-06 mmHg at 25°C.
People can use the following data to convert to the molecule structure.
(1)SMILES: [O-]C(=O)c1ccccc1C(=O)c2ccc(O)cc2.s1cccc1/C(c2sccc2)=C3\CCC[NH+](C)C3
(2)InChI: InChI=1/C15H17NS2.C14H10O4/c1-16-8-2-5-12(11-16)15(13-6-3-9-17-13)14-7-4-10-18-14;15-10-7-5-9(6-8-10)13(16)11-3-1-2-4-12(11)14(17)18/h3-4,6-7,9-10H,2,5,8,11H2,1H3;1-8,15H,(H,17,18)
(3)InChIKey: KEEAAKGKVVTPOM-UHFFFAOYAX
(4)Std. InChI: InChI=1S/C15H17NS2.C14H10O4/c1-16-8-2-5-12(11-16)15(13-6-3-9-17-13)14-7-4-10-18-14;15-10-7-5-9(6-8-10)13(16)11-3-1-2-4-12(11)14(17)18/h3-4,6-7,9-10H,2,5,8,11H2,1H3;1-8,15H,(H,17,18)
(5)Std. InChIKey: KEEAAKGKVVTPOM-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 1440mg/kg (1440mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 24, Pg. 2331, 1982. | |
mouse | LD50 | oral | 10gm/kg (10000mg/kg) | Drugs in Japan Vol. 6, Pg. 463, 1982. | |
rat | LD50 | intraperitoneal | 1122mg/kg (1122mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 24, Pg. 2331, 1982. | |
rat | LD50 | oral | 10gm/kg (10000mg/kg) | Drugs in Japan Vol. 6, Pg. 463, 1982. |